ArticleVaccines2025

Allo-Priming Reverses Immunosenescence and May Restore Broad Respiratory Viral Protection and Vaccine Responsiveness to the Elderly: Results of a Phase I/II Clinical Trial.

Canhui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.